Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Small Molecules
    • 1.2.1.2 Enzymes
    • 1.2.1.3 Blood and Blood Components
    • 1.2.1.4 Gene Therapy
    • 1.2.1.5 Recombinant Proteins
    • 1.2.1.6 Somatic Cells
    • 1.2.1.7 Tissues
    • 1.2.1.8 Vaccines
  • 1.2.2 by Application
    • 1.2.2.1 Oncology
    • 1.2.2.2 Radiology
    • 1.2.2.3 Neurology
    • 1.2.2.4 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Small Molecules Market, 2013-2018
  • 4.1.2 Enzymes Market, 2013-2018
  • 4.1.3 Blood and Blood Components Market, 2013-2018
  • 4.1.4 Gene Therapy Market, 2013-2018
  • 4.1.5 Recombinant Proteins Market, 2013-2018
  • 4.1.6 Somatic Cells Market, 2013-2018
  • 4.1.7 Tissues Market, 2013-2018
  • 4.1.8 Vaccines Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Small Molecules Market Forecast, 2019-2024
  • 4.2.2 Enzymes Market Forecast, 2019-2024
  • 4.2.3 Blood and Blood Components Market Forecast, 2019-2024
  • 4.2.4 Gene Therapy Market Forecast, 2019-2024
  • 4.2.5 Recombinant Proteins Market Forecast, 2019-2024
  • 4.2.6 Somatic Cells Market Forecast, 2019-2024
  • 4.2.7 Tissues Market Forecast, 2019-2024
  • 4.2.8 Vaccines Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Oncology Market, 2013-2018
  • 5.1.2 Radiology Market, 2013-2018
  • 5.1.3 Neurology Market, 2013-2018
  • 5.1.4 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Oncology Market Forecast, 2019-2024
  • 5.2.2 Radiology Market Forecast, 2019-2024
  • 5.2.3 Neurology Market Forecast, 2019-2024
  • 5.2.4 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 AstraZeneca
• 8.2 Abbott Laboratories
• 8.3 Amgen Limited & Amgen Ireland Limited
• 8.4 Biogen
• 8.5 Baxter
• 8.6 Bristol-Myers Squibb Company
• 8.7 F. Hoffmann-La Roche
• 8.8 Eli Lilly and Company
• 8.9 Johnson & Johnson
• 8.10 GlaxoSmithKline
• 8.11 Celgene Corporation
• 8.12 Pfizer

9 Conclusion

Summary
The global Solid Tumor Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Small Molecules
Enzymes
Blood and Blood Components
Gene Therapy
Recombinant Proteins
Somatic Cells
Tissues
Vaccines
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AstraZeneca
Abbott Laboratories
Amgen Limited & Amgen Ireland Limited
Biogen
Baxter
Bristol-Myers Squibb Company
F. Hoffmann-La Roche
Eli Lilly and Company
Johnson & Johnson
GlaxoSmithKline
Celgene Corporation
Pfizer
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Oncology
Radiology
Neurology
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa